Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
This study has been completed.
Study NCT00001221 Information provided by National Institutes of Health Clinical Center (CC)
First Received on November 3, 1999. Last Updated on March 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gonadal Dysgenesis
Turner's Syndrome
Additional conditions recognized in this trial
Congenital Abnormalities
Primary Ovarian Insufficiency
Turner Syndrome
More general conditions related to this trial
Adnexal Diseases
Cardiovascular Abnormalities
Cardiovascular Diseases
Chromosome Disorders
Disorders of Sex Development
Endocrine System Diseases
Genetic Diseases, Inborn
Genital Diseases, Female
Gonadal Disorders
Heart Defects, Congenital
Heart Diseases
Ovarian Diseases
Sex Chromosome Disorders
Sex Chromosome Disorders of Sex Development
Urogenital Abnormalities
Interventions listed in this trial
Growth Hormone (Humatrope)
Additional drug interventions recognized in this trial
Estradiol
Ethinyl Estradiol
Hormones
More general drug interventions related to this trial
Estrogens
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Back to top of Main Content